4//SEC Filing
McLoughlin Dennis 4
Accession 0001209191-19-035115
CIK 0001396814other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:50 PM ET
Size
9.8 KB
Accession
0001209191-19-035115
Insider Transaction Report
Form 4
McLoughlin Dennis
Chief Commercial Officer
Transactions
- Sale
Common Stock
2019-06-04$42.91/sh−1,099$47,158→ 13,822 total - Award
Common Stock
2019-06-05+5,600→ 19,422 total - Award
Stock Option (Right to Buy)
2019-06-05+33,800→ 33,800 totalExercise: $43.54Exp: 2029-06-05→ Common Stock (33,800 underlying)
Footnotes (4)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]Includes 88 shares of common stock acquired under the issuer's employee stock purchase plan in December 2018.
- [F3]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2020, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F4]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001752004
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:50 PM ET
- Size
- 9.8 KB